Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal chemistry strategies for the development of phosphodiesterase 10A (PDE10A) inhibitors - An update of recent progress
Harsh S. Amin, Palak K. Parikh, Manjunath Ghate
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113155-113155
Closed Access | Times Cited: 11

Showing 11 citing articles:

Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds
Aleksandra Leśniewska, Piotr Przybylski
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116556-116556
Open Access | Times Cited: 11
An insight from computational approach to explore novel, high-affinity phosphodiesterase 10A inhibitors for neurological disorders
Bhanu Sharma, Dhananjay Bhattacherjee, Grigory V. Zyryanov, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9424-9436
Closed Access | Times Cited: 37
Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases
Qi Li, Qinghong Liao, Shulei Qi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116386-116386
Closed Access | Times Cited: 6
Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece
Bill W. G. L. Chan, Nicholas B. Lynch, Wendy Tran, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 6
Discovery of Novel Azetidine-based Imidazopyridines as Selective and Orally Bioavailable Inhibitors of Phosphodiesterase 10A for the Treatment of Pulmonary Arterial Hypertension
Hongzhe Huang, Hongxiang Xue, Anqi Cai, et al.
European Journal of Medicinal Chemistry (2025) Vol. 290, pp. 117537-117537
Closed Access
Regional and aging-specific cellular architecture of non-human primate brains
Yun-Mei Wang, Wenchao Wang, Yongzhang Pan, et al.
Genome Medicine (2025) Vol. 17, Iss. 1
Open Access
Comparative Hypothalamic Transcriptome Analysis Reveals Crucial mRNAs, lncRNAs, and circRNAs Affecting Litter Size in Goats
Shucan Dong, Biwei Hou, Chuang Yang, et al.
Genes (2023) Vol. 14, Iss. 2, pp. 444-444
Open Access | Times Cited: 8
Current emerging therapeutic targets and clinical investigational agents for schizophrenia: Challenges and opportunities
Na Ye, Qi Wang, Yue Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 2
THPP-1 PDE10A inhibitor reverses the cognitive deficits and hyperdopaminergic state in a neurodevelopment model of schizophrenia
Daniela L. Uliana, Ángela Martínez, Anthony A. Grace
Schizophrenia Research (2024) Vol. 274, pp. 315-326
Open Access | Times Cited: 1
Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer
Anna V. Ivanina Foureau, Wei Sha, David M. Foureau, et al.
Translational Lung Cancer Research (2022) Vol. 11, Iss. 12, pp. 2464-2476
Open Access | Times Cited: 5
Discovery of 3-trifluoromethyl-substituted pyrazoles as selective phosphodiesterase 10A inhibitors for orally attenuating isoprenaline-induced cardiac hypertrophy
Yuan Han, F F Zhang, Hongzhe Huang, et al.
Chinese Chemical Letters (2024), pp. 109965-109965
Closed Access
On the Biological Importance, Preparation, and Uses of Imidazo[1,2-b]pyridazine-Based Compounds
Barbaros Akkurt
Journal of the Turkish Chemical Society Section A Chemistry (2021) Vol. 8, Iss. 4, pp. 1217-1250
Open Access
Page 1

Scroll to top